$212M Botox Jury Award Makes Strong Point About Dangerous and Defective Drugs
What happens when a drug maker fails to provide adequate warnings to health care providers and patients about harmful, sometimes deadly, adverse effects? This was the central question of a series of lawsuits our Virginia defective and dangerous products law firm reported on in 2011. In those cases, the company behind Botox, Allergan, faced billions…